G-treeBNT
Business Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
116 Village Blvd Ste 200, Princeton, New...Phone Number
+82 317867800Website
www.gtreebnt.comRevenue
$17.4 MillionIndustry
About G-treeBNT
GtreeBNT Co., Ltd. (www.gtreebnt.com) is a clinical development pharmaceutical company listed on the Korean stock market that aims to acquire the rights to early clinical stage pipeline pharmaceuticals targeted at diseases with unmet needs, including rare diseases. GtreeBNT plans to rapidly develop the pharmaceuticals through additional studies, formulation development, and clinical trials for commercialization. Currently, its U.S. subsidiary, ReGenTree, LLC (www.regentreellc.com), is conducting a second Phase 3 clinical trial (ARISE-2) for dry eye syndrome (DES) and a Phase 3 trial (SEER-1) for the orphan ocular disease neurotrophic keratopathy (NK) using RGN-259 eye drops. In addition, GtreeBNT is conducting a Phase 1b trial for the orphan disease glioblastoma multiforme (GBM) using OKN-007 in U.S.Explore more
G-treeBNT Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to G-treeBNT
Compare insights from companies similar to G-treeBNT, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
G-treeBNT Tech Stack
A closer look at the technologies used by G-treeBNT
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding G-treeBNT
Sign Up For FreeTo access detailed company insights
GtreeBNT Co., Ltd. (www.gtreebnt.com) is a clinical development pharmaceutical company listed on the Korean stock market that aims to acquire the rights to early clinical stage pipeline pharmaceuticals targeted at diseases with unmet needs, including rare diseases. GtreeBNT plans to rapidly develop the pharmaceuticals through additional studies, fo... Read More
